Crypto
AAVE Community Challenges Aave Labs Over Governance and Control
Conflict is emerging within AAVE as the community accuses Aave Labs of acting unilaterally, diverting protocol revenues through a new partnership. Despite AAVE’s success as Ethereum’s leading lending protocol, governance tensions highlight DAO challenges. A proposed “poison pill” could curb Labs’ control, testing whether compromise can preserve decentralization, profitability, and trust within decentralized finance governance.
The community is supposed to use AAVE as a ballot to decide the direction of the successful DeFi protocol. However, Aave Labs appears to be acting unilaterally and is therefore facing resistance, leading to conflict.
AAVE is by far the most important decentralized protocol for lending on Ethereum (ETH), and its success is reflected in fee revenues approaching $1 billion this year. However, a conflict is currently brewing between the community and the founders, who, through Aave Labs, exert deep control over day-to-day operations. This dispute is a prime example of the difficulties that supposedly self-governing projects face.
The token essentially serves as a vote in strategic decisions; such concepts are known as Decentralized Autonomous Organizations (DAOs) . Now, a “poison pill” is being proposed by the community to curtail Aave Labs’ influence.
AAVE Labs diverted revenue to itself – DAO community outraged
This follows the Labs’ unilateral decision in early December to enter into a partnership with CoW Swaps. The resulting fee revenue flows to Aave Labs, whereas with their previous partner, Paraswap, revenue went to the AAVE DAO self-governing body. Therefore, the “poison pill” proposal, which “tulipking” intends to put to a community vote, calls for a decision to sue the Labs.
The proposal demands that the company transfer its software code, copyrights, and trademark rights to the community, relinquish assets, and transfer collected fees. In other words, the AAVE DAO self-governing body should take over Aave Labs because they feel cheated.
Aave founder Stani Kulechov, who now serves as CEO of Aave Labs, attempted to downplay the sharply criticized move towards CoW swaps. He wrote in the online discussion that this action should have been put up for discussion beforehand and that more transparency should have been provided. Now, however, he remains silent, as the “poison pill” is being directed at him through Aave Labs. For the moment, the proposal to sue Aave Labs for a potential procedural error will not be put to a preliminary vote, but that could change very quickly.
Conclusion: Is AAVE’s success story jeopardized by internal conflicts?
Several initiatives have already been launched this year by the community, including a token buyback program and the abandonment of protocol presence on blockchains that have proven unprofitable. AAVE’s self-governance is therefore fundamentally functioning, and this could persuade Labs to compromise.
Both parties have a strong interest in the company remaining profitable and preventing public infighting that damages its image and business model. However, the grassroots democracy inherent in a DAO is a complex and challenging process – in AAVE’s case, it apparently also serves as a check on Labs.
__
(Featured image by Markus Winkler via Unsplash)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in BLOCK-BUILDERS.DE. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Biotech7 days agoJohnson & Johnson’s Tecvayli Combo Shows Breakthrough Results in Multiple Myeloma
-
Impact Investing2 weeks agoEU Drops 2029 Gas Boilers Ban but Ends Incentives from 2025 in Shift Toward Cleaner Heating
-
Cannabis2 days agoTrump Signals Historic Shift: U.S. Weighs Reclassifying Cannabis from Schedule I to III
-
Impact Investing1 week agoEuropean Sustainability Week 2025: Advancing ESG Amid Uncertainty



